Canton Strategic Holdings, Inc. (CNTN)
1.68
-0.02
(-0.88%)
USD |
NASDAQ |
Oct 19, 15:47
Canton Strategic Holdings EPS Diluted (Quarterly) : -0.0888 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0888 |
| March 31, 2026 | -0.2279 |
| December 31, 2025 | -0.7927 |
| September 30, 2025 | -0.3367 |
| June 30, 2025 | -0.6448 |
| March 31, 2025 | -0.988 |
| December 31, 2024 | -1.936 |
| September 30, 2024 | -2.453 |
| June 30, 2024 | -2.416 |
| March 31, 2024 | -2.878 |
| December 31, 2023 | -3.161 |
| September 30, 2023 | -39.46 |
| June 30, 2023 | -58.62 |
| Date | Value |
|---|---|
| March 31, 2023 | -87.56 |
| December 31, 2022 | -57.53 |
| September 30, 2022 | -69.18 |
| June 30, 2022 | -53.04 |
| March 31, 2022 | -104.35 |
| December 31, 2021 | 80.94 |
| September 30, 2021 | -31.09 |
| June 30, 2021 | -56.68 |
| March 31, 2021 | -81.96 |
| September 30, 2020 | -15.08 |
| June 30, 2020 | -8.794 |
| March 31, 2020 | -16.97 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | -0.0464 |
| Anixa Biosciences, Inc. | -0.0762 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.95M |
| Revenue (Quarterly) | 1.496M |
| Total Expenses (Quarterly) | 19.45M |
| Enterprise Value | 93.74M |
| Profit Margin (Quarterly) | -1.20K% |
| Earnings Yield | -86.08% |
| Normalized Earnings Yield | -53.80 |